SJ Medical
Hangzhou SJ Medical Co., Ltd. was established in 2015 and is dedicated to the research, development, manufacturing, and commercialization of vascular interventional medical devices and advanced therapeutic solutions. The company focuses on both cardiovascular and peripheral intervention fields, striving to provide safe, reliable, and innovative solutions for healthcare providers worldwide.
Over the years, SJ Medical has developed a comprehensive product portfolio covering key areas of vascular intervention. Its offerings span from various types of balloon catheters for coronary and peripheral applications to supporting access and diagnostic devices, as well as advanced stent systems. Through continuous innovation and strong R&D capabilities, the company has obtained multiple patents and international certifications, laying a solid foundation for sustainable growth in both domestic and global markets.
The global medical device sector, particularly in the realm of minimally invasive interventional technologies and associated anesthetic support systems, is experiencing exponential growth. Driven by an aging global population, the rising prevalence of cardiovascular diseases, and technological breakthroughs in polymer chemistry and laser micromachining, healthcare ecosystems demand ultra-precision, high-reliability instrumentation. As a premier manufacturer rooted in China's robust industrial cluster, SJ Medical bridges the gap between cost efficiency and uncompromising clinical precision.
Looking toward the future, the technology roadmap prioritizes smart-manufacturing integration, AI-assisted surgical navigation compatibility, and biodegradable polymer integrations. By investing heavily in cleanroom automation and real-time optical inspection analytics, we ensure that every catheter, sheath, and stent meets the rigorous demands of modern operating theaters and catheterization laboratories worldwide.
SJ Medical operates a modern manufacturing facility with a total area of approximately 5,000 square meters. The factory is built in accordance with GMP standards and features a high-standard cleanroom environment, including a million-class clean workshop with localized hundred-class areas for critical processes.
The company is supported by a highly experienced technical team, many of whom have been engaged in the medical device industry for decades. Under the leadership of senior engineers, SJ Medical maintains strict quality control and continuously improves its manufacturing processes to ensure product reliability and consistency.
The company is equipped with advanced production and inspection systems, including precision balloon forming equipment, laser welding and marking technologies, and comprehensive laboratory testing facilities. These capabilities ensure high levels of manufacturing accuracy, product consistency, and full-process quality control.
State-of-the-art thermal forming machines ensuring exact wall thickness, burst pressure resistance, and radial compliance for cardiac interventions.
High-precision fiber laser systems dedicated to manufacturing intricate nickel-titanium tube stents and micro-catheter components.
Rigorous analytical instruments evaluating tensile strength, trackability, pushability, and biocompatibility under simulated physiological conditions.
SJ Medical focuses on the development of vascular interventional devices designed for both coronary and peripheral procedures. Its product range integrates interventional access systems, diagnostic catheters, and therapeutic devices, forming a complete solution for minimally invasive vascular treatments. Each product is developed with an emphasis on precision, safety, and clinical performance, aiming to support physicians in achieving optimal procedural outcomes.
The company’s products are widely applied in minimally invasive procedures involving both coronary and peripheral vascular systems. They play an important role in the diagnosis and treatment of vascular diseases, helping to improve procedural efficiency while enhancing patient safety and recovery.
Applied in catheterization labs for angioplasty, stenting, and blockage clearance, ensuring rapid myocardial reperfusion.
Essential for treating peripheral artery diseases, utilizing specialized introducer sheaths and guide wire kits for distal vessel navigation.
Designed for acute stroke and deep vein thrombosis management, delivering safe aspiration and mechanical clot retrieval.
SJ Medical strictly adheres to international quality standards and regulatory requirements. The company has obtained CE certification, ISO 13485 quality management system certification, and CFDA approval, along with free sale certificates, demonstrating its strong commitment to product quality and compliance.
SJ Medical has established long-term partnerships with clients across Europe, Asia, the Middle East, and Africa. Its products are currently distributed in countries such as Finland, Italy, Spain, France, the Netherlands, India, Indonesia, Turkey, and Egypt, among others. The company continues to expand its international footprint and strengthen its global presence.
Finland, Italy, Spain, France, Netherlands
India, Indonesia, and regional medical hubs
Turkey and strategic clinical centers
Egypt and emerging healthcare networks
SJ Medical is committed to providing comprehensive and professional services throughout the entire customer journey. From pre-sales consultation and technical support to efficient order processing and responsive after-sales service, the company ensures that every customer receives timely assistance and reliable solutions.
SJ Medical strictly complies with global regulatory benchmarks and has obtained CE certification, ISO 13485 quality management system certification, and CFDA approval, alongside official Free Sale Certificates.
Our vascular interventional devices are widely utilized in coronary and peripheral vascular procedures, helping physicians perform precise angioplasty, diagnostic access, thrombosis aspiration, and minimally invasive treatments efficiently.
Our products are trusted by long-term partners across Europe (including Italy, France, Spain, Finland, Netherlands), Asia (India, Indonesia), the Middle East (Turkey), and Africa (Egypt).